Literature DB >> 22157695

Establishment of a conversion factor for the Cepheid GeneXpert BCR-ABL assay.

Michelle McNiven, D Talaulikar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22157695     DOI： 10.1097/PAT.0b013e32834e4203

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  4 in total

Review 1.  Molecular monitoring.

Authors:  Simona Soverini; Gianantonio Rosti; Michele Baccarani; Giovanni Martinelli
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

2.  A longitudinal evaluation of performance of automated BCR-ABL1 quantitation using cartridge-based detection system.

Authors:  Anoop Enjeti; Neil Granter; Asma Ashraf; Linda Fletcher; Susan Branford; Philip Rowlings; Susan Dooley
Journal:  Pathology       Date:  2015-10       Impact factor: 5.306

3.  A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.

Authors:  Valentín García-Gutiérrez; María T Gómez-Casares; José M Puerta; Juan M Alonso-Domínguez; Santiago Osorio; Juan C Hernández-Boluda; Rosa Collado; María J Ramírez; Fátima Ibáñez; María L Martín; Juan D Rodríguez-Gambarte; Carolina Martínez-Laperche; Montse Gómez; Dolly V Fiallo; Sara Redondo; Alicia Rodríguez; Concepción Ruiz-Nuño; Juan L Steegmann; Antonio Jiménez-Velasco
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

Review 4.  Molecular techniques for the personalised management of patients with chronic myeloid leukaemia.

Authors:  Mary Alikian; Robert Peter Gale; Jane F Apperley; Letizia Foroni
Journal:  Biomol Detect Quantif       Date:  2017-02-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.